title: Regulation of a neuronal form of focal adhesion kinase by anandamide.
abstract: Anandamide is an endogenous ligand for central cannabinoid receptors and is released after neuronal depolarization. Anandamide increased protein tyrosine phosphorylation in rat hippocampal slices and neurons in culture. The action of anandamide resulted from the inhibition of adenylyl cyclase and cyclic adenosine 3', 5'-monophosphate-dependent protein kinase. One of the proteins phosphorylated in response to anandamide was an isoform of pp125-focal adhesion kinase (FAK+) expressed preferentially in neurons. Focal adhesion kinase is a tyrosine kinase involved in the interactions between the integrins and actin-based cytoskeleton. Thus, anandamide may exert neurotrophic effects and play a role in synaptic plasticity.
authors.affiliation: INSERM U 114, Chaire de Neuropharmacologie, Collège de France, 11 place Marcelin Berthelot, 75231 Paris cedex 05, France.
authors.forename: P
authors.initials: P
authors.lastname: Derkinderen
authors.forename: M
authors.initials: M
authors.lastname: Toutant
authors.forename: F
authors.initials: F
authors.lastname: Burgaya
authors.forename: M
authors.initials: M
authors.lastname: Le Bert
authors.forename: J C
authors.initials: JC
authors.lastname: Siciliano
authors.forename: V
authors.initials: V
authors.lastname: de Franciscis
authors.forename: M
authors.initials: M
authors.lastname: Gelman
authors.forename: J A
authors.initials: JA
authors.lastname: Girault
mesh_terms: D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D016718:Arachidonic Acid / Q000494:pharmacology; D001095:Arachidonic Acids / Q000494:pharmacology*; D015815:Cell Adhesion Molecules / Q000378:metabolism*; D002460:Cell Line; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D017868:Cyclic AMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D063388:Endocannabinoids; D051417:Focal Adhesion Kinase 1; D051416:Focal Adhesion Protein-Tyrosine Kinases; D006624:Hippocampus / Q000187:drug effects / Q000201:enzymology*; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D009473:Neuronal Plasticity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000201:enzymology*; D010766:Phosphorylation; D019000:Phosphotyrosine / Q000378:metabolism; D053284:Polyunsaturated Alkamides; D016548:Prosencephalon; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D051381:Rats; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000378:metabolism
chemical_list: D000067956:Adenylyl Cyclase Inhibitors; D001095:Arachidonic Acids; D015815:Cell Adhesion Molecules; D063388:Endocannabinoids; D053284:Polyunsaturated Alkamides; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; D019000:Phosphotyrosine; D016718:Arachidonic Acid; D000242:Cyclic AMP; D011505:Protein-Tyrosine Kinases; D051417:Focal Adhesion Kinase 1; D051416:Focal Adhesion Protein-Tyrosine Kinases; C496052:Ptk2 protein, rat; D017868:Cyclic AMP-Dependent Protein Kinases; D000262:Adenylyl Cyclases; C078814:anandamide